Dexmedetomidine combined with dezocine for postoperative patient-controlled intravenous analgesia: a meta-analysis

Peng CHEN,Fu-chao CHEN,Ben-hong ZHOU
DOI: https://doi.org/10.13329/j.cnki.zyyjk.2017.0787
2017-01-01
Abstract:[Objective] To evaluate the efficacy and safety of dexmedetomidine combined with dezocine for postoperative patientcontrolled intravenous analgesia (PCIA).[Methods] The randomized controlled trials (RCT) about dexmedetomidine combined with dezocine for PCIA were electronically searched from database of PubMed,Embase,Cochrane library,CNKI and VIP.Rev Man 5.3 software was used to conduct the meta-analysis on the visual analog scale score(VAS),Ramsay score(RSS),Bruggrmann comfort scale (BCS) and adverse reactions.[Results] The VAS scores at 12 hours,24 hours and 48 hours after operation in combination group were lower than those in dezocine group,and the differences were statistically significant (P<0.05).RSS scores showed that the sedation effect within 12 hours after operation in combination group was better than that in dezocine group [WMD=0.84,95%CI (0.18,1.50)].BCS score within 12 hours after operation in combination group was higher than that in dezocine group [WMD=0.57,95%CI(0.28,0.87),P<0.01].The safety results showed that the total incidence rate of adverse reactions,and the incidence rate of nausea,vomiting,dizziness,headache,bradycardia,skin itch and sleepiness in combination group were lower than those in dezocine group.The satisfaction of analgesic effect in combination group was significantly better than that in dezocine group [OR =5.00,95% CI(1.77,14.11),P<0.01].[Conclusion] Compared with dezocine alone,dexmedetomidine combined with dezocine for PCIA has better clinical analgesic effect,and can effectively reduce the incidence rate of adverse reactions with higher security.
What problem does this paper attempt to address?